FDA Approves Blood Thinner Brilinta for Heart Patients (HealthDay)

Heart Disease

HealthDay – WEDNESDAY, July 20 (HealthDay News) — In a long-awaited move,
the U.S. Food and Drug Administration late Wednesday approved the blood
thinner Brilinta (ticagrelor) for use in patients with acute coronary
syndromes, to help lower their odds for heart attack and death.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave